维普中文期刊产品整合服务
19篇 您的检索式:作者名="Ridge T"
    题名 作者 年代 出处 被引量
1Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs显示文摘Khosravan R Wu J T Joseph Ridge N 0,,08:1
2Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel- group study 显示文摘Moretto T J Milton DR Ridge TD 2008Clin Ther2008,30,8:1
3Determination of Pb complexation in oxic and sulfidic waters using pseudovoltammetry显示文摘ROZAN T F LUTHER G W RIDGE D 2003Environmental Science&Technology2003,37,17:1
4Agility and perturbation training for a physically active individual with knee osteoarthritis显示文摘Fitzgerald G Childs J Ridge T 2002Phys Ther2002,82,:1
5Leaf growth characteristics of fast-growing polar hybrids Populus trichocarpa显示文摘Ridge C R Hinckley T M Stettler R E 1986Tree Physiology1986,,1:1
6Structure of white rhinoceros(ceratotherium simum)horn investigated by X-ray computed tomography and histology with implications for growth and external form显示文摘HIERONYMUS T L WITMER L M RIDGELY R C 2006Journal of Morphology2006,267,10:1
7Foot bone marrow edema after 10-week transition to minimalist running shoes显示文摘Ridge S T Johnson A W Mitchell U H 2013Med Sci Sports Exerc2013,45,7:1
8Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel- group study显示文摘Moretto T J Mihon D R Ridge T D 2008Clin Ther2008,30,8:1
9Comparison of safety and tol- erability with continuous ( exenatide once weekly ) or intermittent (exenatide twice daily)GLP-1 receptor agonism in patients with type 2 diabetes显示文摘Ridge T Moretto T Macconell L 2012Diabetes Obes Metab2012,14,12:1
10Efficacy and tolerability of exenatide monotberapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study显示文摘MORETTO T J MILTON D R RIDGE T D 2008Clin Ther2008,30,8:1
11Efficacy and tolerability of exenatide monotherapy over 24weeks in antidiabetic drug nave patients with type 2diabetes:a randomized,double-blind,placebo-controled,parallel-grop study显示文摘Moretto T J Milton D R Ridge T D 2008Clin Ther2008,30,:1
12Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized,double-blind, placebo- controlled, parallel-groupstudy显示文摘Moretto T J Milton DR Ridge TD 2008ClinTher2008,30,:1
13Efficacy and tolerahility of exenatide monotherapy over 24 weeks in antidiabotic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study显示文摘MORETTO T J MILTON D R RIDGE T D 2008Clin Ther2008,30,8:1
14Integrina IIb β inhibi- tor preserves mierovaseular patency in experimental acute focal cerebral isehemie显示文摘Abumiya T Fit ridge R Mazar C 2000Stroke2000,31,6:1
15Comparison of safety and tol- erability with continuous ( exenatide once weekly ) or intermittent ( ex- enatide twice daily) GLP - 1 receptor agonism in patients with type 2 di- abetes显示文摘Ridge T Moretto T MacConell L 2012Diabetes Obes Metab2012,14,12:1
16Efficacy and tolerability of exenatidemonotherapy over 24 weeks in antidiabetic drug-naive patients with type2diabetes: a randomized, double-blind, placebo-controlled, parallel-group study显示文摘Moretto T Milton D Ridge T 2008Clin Ther2008,30,:1
17Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study 显示文摘Moretto T J Milton DR Ridge TD 2008Clin Ther2008,30,8:1
18Johne's disease in al- pacas ( Lama pacos) in Australia 显示文摘Ridge S E Harkin J T Badman R T 1995Australian Veterinary Jour-nal1995,72,4:1
19Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidibetic drug-naive patients with type 2 diabetes : a randomized, double-blind, placebo-controlled,parallel-group study显示文摘Moretto T J Milton D R Ridge T D 2008Clinieal Therapeutics2008,30,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费